TIFFANY JORDAN: Open Payments
NPI 1275779423 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,468 in 91 payments from 16 companies in 2025. Trend: 2023 $1,275 · 2024 $1,722 · 2025 $1,468
Food & beverage: $1,468
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $266 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $214 |
| Otsuka America Pharmaceutical, Inc. | 16 | $187 |
| Corium, LLC | 7 | $161 |
| Supernus Pharmaceuticals, Inc. | 5 | $111 |
| Lundbeck LLC | 5 | $96 |
| Teva Pharmaceuticals USA, Inc. | 5 | $92 |
| Vanda Pharmaceuticals Inc. | 5 | $83 |
| Vertical Pharmaceuticals, LLC | 2 | $72 |
| Collegium Pharmaceutical, Inc. | 3 | $54 |
Products named: VRAYLAR, REXULTI, CAPLYTA, Azstarys, Qelbree, AUSTEDO XR, FANAPT, Relexxii.
Industry payments across AZ — which companies pay providers there.
